Breton Michael Asken

Breton Michael Asken

Auto-generated profile, based on publicly available information

Breton Michael Asken

Department of Clinical and Health Psychology, University of Florida, Gainesville

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Journal of Athletic Training
Verified
Journal Article
Closed access
BABreton M. Asken
Breton M. Asken
MMMichael A. McCrea
Michael A. McCrea
JCJames R. Clugston
James R. Clugston
S Aliyah R. Snyder
Aliyah R. Snyder
ZHZachary M. Houck
Zachary M. Houck
RBRussell M. Bauer
Russell M. Bauer
Preclinical research has demonstrated a window of vulnerability in the immediate aftermath of concussion wherein continued activity and stimulation can impair or prolong neurobehavioral recovery. However, this concept has not been quantified in a human population.Context: To examine the effect of delayed reporting and removal from athletic activity after concussion on recovery time.Objective: Cross-sectional study.Design: A National Collegiate Athletic Association Division I university.Setting: Ninety-seven athletes who sustained a sport-related concussion between 2008 and 2015 were analyzed (age = 20.4 ± 1.3 years). Athletes were grouped as immediate removal from activity (I-RFA) or delayed removal from activity (D-RFA).Patients or Other Participants: Days missed was defined as the number of days between the concussion-causing event and clearance for return to contact. Associations between RFA group and prolonged (8 or more days') versus normal (7 or fewer days') recovery were also analyzed.Main Outcome Measure(s): Fifty (51.5%) of the 97 athletes did not immediately report concussion symptoms. The D-RFA athletes averaged 4.9 more days missed than the I-RFA athletes. Membership in the specific RFA group predicted days missed even after controlling for sex, concussion history, learning disability or attention-deficit/hyperactivity disorder diagnosis, diagnosed psychological disorder, and acute symptom severity (R 2 change = 0.097, β = .319, P = .002). The D-RFA athletes were approximately 2.2 times more likely to have a prolonged recovery (8 or more days) compared with the I-RFA athletes (χ2 = 10.268, P = .001, φ = 0.325).Results: Athletes who do not immediately report symptoms of a concussion and continue to participate in athletic activity are at risk for longer recoveries than athletes who immediately report symptoms and are immediately removed from activity. Continuing to participate in athletic activity during the immediate aftermath of a concussion potentially exposes the already injured brain to compounded neuropathophysiologic processes.Conclusions:

20 March 2018 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
BABreton M. Asken
Breton M. Asken
RBRussell M. Bauer
Russell M. Bauer
KGKevin M. Guskiewicz
Kevin M. Guskiewicz
MMMichael A. McCrea
Michael A. McCrea
JSJulianne D. Schmidt
Julianne D. Schmidt
SSSteven Svoboda
Steven Svoboda
Background: Timely removal from activity after concussion symptoms remains problematic despite heightened awareness. Previous studies indicated potential adverse effects of continuing to participate in physical activity immediately after sustaining a concussion. Hypothesis/Purpose: The purpose was to determine the effect of timing of removal from play after concussion on clinical outcomes. It was hypothesized that immediate removal from activity after sport-related concussion (SRC) would be associated with less time missed from sport, a shorter symptomatic period, and better outcomes on acute clinical measures. Study Design: Cohort study; Level of evidence, 3. Methods: Data were reported from the National Collegiate Athletic Association and Department of Defense Grand Alliance: Concussion Awareness, Research, and Education (CARE) Consortium. Participants with 506 diagnosed SRCs from 18 sports and 25 institutions and military service academies were analyzed and classified as either immediate removal from activity (I-RFA) or delayed removal from activity (D-RFA). Outcomes of interest included time missed from sport attributed to their SRC, symptom duration, and clinical assessment scores. Results: There were 322 participants (63.6%) characterized as D-RFA. I-RFA status was associated with significantly less time missed from sport ( R 2 change = .022-.024, P < .001 to P = .001) and shorter symptom duration ( R 2 change = .044-.046, P < .001 [all imputations]) while controlling for other SRC recovery modifiers. These athletes missed approximately 3 fewer days from sport participation. I-RFA athletes had significantly less severe acute SRC symptoms and were at lower risk of recovery taking ≥14 days (relative risk = .614, P < .001, small-medium effect size) and ≥21 days (relative risk = .534, P = .010, small effect size). Conclusion: I-RFA is a protective factor associated with less severe acute symptoms and shorter recovery after SRC. Conveying this message to athletes, coaches, and others involved in the care of athletes may promote timely injury reporting.

24 March 2017 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
BABreton Michael Asken
Breton Michael Asken
SDSteven Trent DeKosky
Steven Trent DeKosky
JCJames R. Clugston
James R. Clugston
MJMichael S. Jaffee
Michael S. Jaffee
RBRussell M. Bauer
Russell M. Bauer

2 February 2021 in Journal of NeuroVirology
Verified
Journal Article
Open access
PDF file
JHJoanna Hellmuth
Joanna Hellmuth
TBT. Allen Barnett
T. Allen Barnett
BABreton M. Asken
Breton M. Asken
JKJohn Daniel Kelly
John Daniel Kelly
LTLeonel Torres
Leonel Torres
MPMichael J. Peluso
Michael J. Peluso
As cases of coronavirus disease 2019 (COVID-19) mount worldwide, attention is needed on potential long-term neurologic impacts for the majority of patients who experience mild to moderate illness managed as outpatients. To date, there has not been discussion of persistent neurocognitive deficits in patients with milder COVID-19. We present two cases of non-hospitalized patients recovering from COVID-19 with persistent neurocognitive symptoms. Commonly used cognitive screens were normal, while more detailed testing revealed working memory and executive functioning deficits. An observational cohort study of individuals recovering from COVID-19 (14 or more days following symptom onset) identified that among the first 100 individuals enrolled, 14 were non-hospitalized patients reporting persistent cognitive issues. These 14 participants had a median age of 39 years (interquartile range: 35–56), and cognitive symptoms were present for at least a median of 98 days (interquartile range: 71–120 following acute COVID-19 symptoms); no participants with follow-up evaluation reported symptom resolution. We discuss potential mechanisms to be explored in future studies, including direct viral effects, indirect consequences of immune activation, and immune dysregulation causing auto-antibody production.

1 January 2018 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
MSMolly J. Sullan
Molly J. Sullan
BABreton M. Asken
Breton M. Asken
MJMichael S. Jaffee
Michael S. Jaffee
SDSteven Trent DeKosky
Steven Trent DeKosky
RBRussell M. Bauer
Russell M. Bauer

1 October 2017 in JAMA Neurology
Verified
Journal Article
Closed access
PDF file
BABreton M. Asken
Breton M. Asken
MSMolly J. Sullan
Molly J. Sullan
SDSteven Trent DeKosky
Steven Trent DeKosky
MJMichael S. Jaffee
Michael S. Jaffee
RBRussell M. Bauer
Russell M. Bauer
Importance Scientific and lay interest in negative outcomes associated with exposure to repetitive brain trauma (RBT) continues to strengthen. Concerns about the association between RBT and dementia began more than a century ago, but have resurfaced in the last decade with the more recently described chronic traumatic encephalopathy (CTE). Chronic traumatic encephalopathy is a tauopathy associated with RBT that has become inextricably linked to conversations about sport-related concussion and mild traumatic brain injury. Accordingly, specific populations such as collision sport athletes and certain military personnel are of particular interest owing to their unique exposure to RBT. The gaps and controversies in our understanding of the epidemiologic factors, mechanism, and clinicopathological correlates of CTE reflect the current reliance on postmortem case series investigations. This review discusses the state of the science of CTE and raises considerations for researching and interpreting cognitive changes in members of at-risk populations. Observations The recent development of pathological diagnostic criteria for CTE represented an important step for differentiating CTE from other neurodegenerative diseases. By comparison, defining the clinical syndrome(s) associated with CTE and the necessary and sufficient symptoms needed for its diagnosis lags behind. The absence of validated in vivo biomarkers of pathological characteristics of CTE and longitudinal tracking with neuropsychological evaluation remains a significant hurdle. Attribution of candidate symptoms in retired athletes to CTE is complicated by the presence of multiple premorbid and comorbid factors affecting cognitive reserve that influence normal or expected cognitive functioning. This is a critical issue in appropriately defining reference groups for normative comparisons. Conclusions and Relevance Available data, while limited and complicated by selection bias, indicate that exposure to RBT represents the greatest risk factor for CTE pathological features, although clinicopathological correlates and the nature of onset and progression of symptoms are largely unknown. Considering aspects of cognitive reserve is likely essential for both interpreting cognitive outcomes associated with CTE and for developing preventive treatment programs. Research on CTE would benefit greatly from incorporating principles established within other areas of neurodegenerative disease and the nuances of clinicopathological considerations.